Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Amazon
AMZN
|
$529M |
| 2 |
Apple
AAPL
|
$498M |
| 3 |
Procter & Gamble
PG
|
$497M |
| 4 |
Elanco Animal Health
ELAN
|
$467M |
| 5 |
AbbVie
ABBV
|
$397M |
Top Sells
| 1 |
Microsoft
MSFT
|
$696M |
| 2 |
Intuit
INTU
|
$535M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$503M |
| 4 |
Intercontinental Exchange
ICE
|
$459M |
| 5 |
Boeing
BA
|
$420M |
Sector Composition
| 1 | Technology | 28.58% |
| 2 | Healthcare | 18.93% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
American Tower
AMT
$95.5B
| $888M | 0.61% |
4,078,584
-454,912
| -10% | -$99M |
|
|
27
AbbVie
ABBV
$374B
| $877M | 0.6% |
11,515,689
+5,208,549
| +83% | +$397M |
|
28
Nike
NKE
$110B
| $861M | 0.59% |
10,406,903
-408,864
| -4% | -$33.8M |
|
29
CoStar Group
CSGP
$37.9B
| $838M | 0.58% |
1,427,479
-268,403
| -16% | -$158M |
|
30
SS&C Technologies
SSNC
$21.7B
| $830M | 0.57% |
18,951,786
-33,585
| -0.2% | -$1.47M |
|
|
CTLT
31
DELISTED
CATALENT, INC.
CTLT
| $819M | 0.56% |
15,761,948
-755,253
| -5% | -$39.2M |
|
32
Progressive
PGR
$145B
| $771M | 0.53% |
10,444,401
-1,657,742
| -14% | -$122M |
|
33
Blackstone
BX
$134B
| $769M | 0.53% |
16,881,796
-1,054,601
| -6% | -$48.1M |
|
34
Aon
AON
$79.1B
| $749M | 0.52% |
4,536,962
-20,253
| -0.4% | -$3.34M |
|
35
Nice
NICE
$8.73B
| $737M | 0.51% |
5,133,877
+500,624
| +11% | +$71.9M |
|
36
Altria Group
MO
$113B
| $723M | 0.5% |
18,699,294
-573,828
| -3% | -$22.2M |
|
37
Danaher
DHR
$147B
| $717M | 0.49% |
5,180,810
-29,834
| -0.6% | -$4.13M |
|
38
Thermo Fisher Scientific
TMO
$186B
| $716M | 0.49% |
2,526,437
-252,089
| -9% | -$71.5M |
|
39
Intel
INTC
$106B
| $702M | 0.48% |
12,973,250
-312,262
| -2% | -$16.9M |
|
|
40
Elanco Animal Health
ELAN
$9.12B
| $689M | 0.47% |
30,788,858
+20,846,120
| +210% | +$467M |
|
|
41
Alphabet (Google) Class A
GOOGL
$2.56T
| $687M | 0.47% |
591,399
-45,368
| -7% | -$52.7M |
|
42
Alibaba
BABA
$330B
| $676M | 0.47% |
3,477,971
-1,827,269
| -34% | -$355M |
|
43
Steris
STE
$24.1B
| $665M | 0.46% |
4,750,853
-657,780
| -12% | -$92.1M |
|
44
Eli Lilly
LLY
$657B
| $663M | 0.46% |
4,778,042
-486,130
| -9% | -$67.4M |
|
45
Neurocrine Biosciences
NBIX
$13.8B
| $660M | 0.45% |
7,629,199
+255,687
| +3% | +$22.1M |
|
46
Humana
HUM
$36.5B
| $657M | 0.45% |
2,091,276
+546,774
| +35% | +$172M |
|
47
Walt Disney
DIS
$213B
| $650M | 0.45% |
6,727,641
-507,244
| -7% | -$49M |
|
48
Accenture
ACN
$162B
| $644M | 0.44% |
3,945,079
+84,172
| +2% | +$13.7M |
|
49
Broadridge
BR
$29.9B
| $617M | 0.42% |
6,505,192
+358,193
| +6% | +$34M |
|
50
CME Group
CME
$96B
| $609M | 0.42% |
3,522,024
-536,433
| -13% | -$92.8M |
|